Brendan Smith - 14 Oct 2022 Form 4 Insider Report for CRISPR Therapeutics AG (CRSP)

Role: Chief Financial Officer
Signature: /s/ Elizabeth Ryland Waldinger, attorney-in-fact
Issuer symbol: CRSP
Transactions as of: 14 Oct 2022
Net transactions value: -$61,949
Form type: 4
Filing time: 18 Oct 2022, 17:38:29 UTC
Previous filing: 12 Oct 2022
Next filing: 22 Feb 2023
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	CRSP	Common Shares	Options Exercise		+3,750			3,750	14 Oct 2022	Direct	F1, F2
transaction	CRSP	Common Shares	Tax liability	$61,949	-1,111	-30%	$55.76	2,639	17 Oct 2022	Direct	F3

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	CRSP	Restricted Stock Units	Options Exercise		+3,750	+50%		11,250	14 Oct 2022	Common Shares	3,750		Direct	F1, F2

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	The restriced stock units shall vest as follows: (i) one quarter of the shares shall vest on October 14, 2022, (ii) one quarter of the shares shall vest on October 14, 2023, (iii) one quarter of the shares shall vest on October 14, 2024, and (iv) one quarter of the shares shall vest on October 14, 2025.
F2	Each restricted stock unit represents a contingent right to receive one share of CRSP Common Shares.
F3	On October 14, 2021, the reporting person was granted 15,000 restricted stock units. On October 14, 2022, 3,750 restricted stock units vested. Amount reported represents the number of shares required to be sold by the reporting person to cover the tax withholding obligation in connection with the vesting of these restricted stock units. This sale is mandated by the Company's RSU Settlement Policy to fund the tax withholding obligation and does not represent a discretionary trade by the reporting person.